Miller Seline E.
- SEC CIK
- 0001769866
No open-market purchases or sales filed in the past year.
Current role at each company
- GYRE Gyre Therapeutics, Inc.SVP Finance; Interim CFO & PAOas of Sep 1, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Miller Seline E. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2022 (view filing)5:19 PM ET | Aug 9 | 1 day | Miller Seline E.SVP Finance; Interim CFO & PAO | PPurchase | +3.25K | $0.47 | +$1.53K | +100.0%6.50K after | |
| Feb 16, 2022 (view filing)8:10 PM ET | Feb 9 | 7 daysLate | Miller Seline E.SVP Finance; Interim CFO & PAO | PPurchase | +3.25K | $0.46 | +$1.50K | New position3.25K after |